AstraZeneca PLC aims for $80 billion revenue by 2030 through strong growth in oncology, biopharmaceuticals, and rare diseases ...

“It’s a renewed commitment to our mission,” says Paczyński, “offering improved, well-supported editions of the classics that ...

Norwegian Cruise Line's Q3 results beat analyst estimates for both EPS and revenue. See why I upgrade my rating on NCLH stock ...

Imagine using artificial intelligence to compare two seemingly unrelated creations—biological tissue and Beethoven's ...